Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 245

    1.

    What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?

    Brooks JT, Kaplan JE, Masur H.

    Top HIV Med. 2009 Jul-Aug;17(3):109-14. Review.PMID: 19675369 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.

    Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE; HIV Medicine Association of the Infectious Diseases Society of America.

    Clin Infect Dis. 2009 Sep 1;49(5):651-81.PMID: 19640227 [PubMed - indexed for MEDLINE]Related articles

    3.

    New guidelines for the management of HIV-related opportunistic infections.

    Masur H, Kaplan JE.

    JAMA. 2009 Jun 10;301(22):2378-80. No abstract available. PMID: 19509385 [PubMed - indexed for MEDLINE]Related articles

    4.

    Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

    Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America.

    MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4.PMID: 19357635 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines.

    Brooks JT, Kaplan JE, Holmes KK, Benson C, Pau A, Masur H.

    Clin Infect Dis. 2009 Mar 1;48(5):609-11. Review. No abstract available. PMID: 19191648 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rhythmic patterns in phagocytosis and the production of reactive oxygen species by zebrafish leukocytes.

    Kaplan JE, Chrenek RD, Morash JG, Ruksznis CM, Hannum LG.

    Comp Biochem Physiol A Mol Integr Physiol. 2008 Dec;151(4):726-30. Epub 2008 Aug 31.PMID: 18793741 [PubMed - in process]Related articles

    7.

    Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States: 1994-2003.

    Teshale EH, Hanson DL, Wolfe MI, Brooks JT, Kaplan JE, Bort Z, Sullivan PS; Adult and Adolescent Spectrum of HIV Disease Study Group.

    Clin Infect Dis. 2007 Mar 15;44(6):879-83. Epub 2007 Feb 1. No abstract available. PMID: 17304464 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

    Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA.

    N Engl J Med. 2006 Sep 14;355(11):1141-53.PMID: 16971720 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.

    Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA; for the Global AIDS Policy Model Investigators.

    AIDS. 2005 Aug 12;19(12):1299-308.PMID: 16052085 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.

    Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK; CDC; National Institutes of Health; Infectious Diseases Society of America.

    MMWR Recomm Rep. 2004 Dec 17;53(RR-15):1-112. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Apr 1;54(12):311. PMID: 15841069 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Diagnosis, treatment, and prevention of selected common HIV-related opportunistic infections in the Caribbean region.

    Kaplan JE.

    Top HIV Med. 2004 Dec-2005 Jan;12(5):136-41. Review.PMID: 15647609 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Current epidemiology of Pneumocystis pneumonia.

    Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, Huang L, Beard CB, Kaplan JE.

    Emerg Infect Dis. 2004 Oct;10(10):1713-20. Review.PMID: 15504255 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

    Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE; HIV Medicine Association of the Infectious Diseases Society of America.

    Clin Infect Dis. 2004 Sep 1;39(5):609-29. Epub 2004 Aug 11. No abstract available. PMID: 15356773 [PubMed - indexed for MEDLINE]Related articles

    14.

    The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.

    Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma JG, Douglas JM Jr, LaLota M, Dickinson G, Schwarcz S, Torian L, Wendell D, Paul S, Goza GA, Ruiz J, Boyett B, Kaplan JE.

    J Infect Dis. 2004 Jun 15;189(12):2174-80. Epub 2004 May 21.PMID: 15181563 [PubMed - indexed for MEDLINE]Related articles

    15.

    When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL.

    Kaplan JE, Hanson DL, Cohn DL, Karon J, Buskin S, Thompson M, Fleming P, Dworkin MS; Adult and Adolescent Spectrum of HIV Disease Project Investigators.

    Clin Infect Dis. 2003 Oct 1;37(7):951-8. Epub 2003 Sep 12.PMID: 13130408 [PubMed - indexed for MEDLINE]Related articles

    16.

    A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.

    García-Lerma JG, MacInnes H, Bennett D, Reid P, Nidtha S, Weinstock H, Kaplan JE, Heneine W.

    J Virol. 2003 May;77(10):5685-93.PMID: 12719561 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

    Masur H, Kaplan JE, Holmes KK; U.S. Public Health Service; Infectious Diseases Society of America.

    Ann Intern Med. 2002 Sep 3;137(5 Pt 2):435-78.PMID: 12617574 [PubMed - indexed for MEDLINE]Related articles

    18.

    Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

    Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

    Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.PMID: 12617573 [PubMed - indexed for MEDLINE]Related articles

    19.

    Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

    Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

    MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.PMID: 12412613 [PubMed - indexed for MEDLINE]Related articles

    20.

    Discontinuing prophylaxis against recurrent opportunistic infections in HIV-infected persons: a victory in the era of HAART.

    Kaplan JE, Masur H, Holmes KK.

    Ann Intern Med. 2002 Aug 20;137(4):285-7. No abstract available. PMID: 12186519 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

    Kaplan JE, Masur H, Holmes KK; USPHS; Infectious Disease Society of America.

    MMWR Recomm Rep. 2002 Jun 14;51(RR-8):1-52.PMID: 12081007 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

    Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

    MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.PMID: 12027060 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.

    Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR 3rd, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA.

    Arch Intern Med. 2002 Apr 22;162(8):921-8.PMID: 11966344 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Preventing opportunistic infections among human immunodeficiency virus-infected adults in African countries.

    Grant AD, Kaplan JE, De Cock KM.

    Am J Trop Med Hyg. 2001 Dec;65(6):810-21. Review.PMID: 11791979 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents.

    Kaplan JE, Hanson DL, Jones JL, Dworkin MS; Adult and Adolescent Spectrum of HIV Disease Project Investigators.

    AIDS. 2001 Sep 28;15(14):1831-6.PMID: 11579245 [PubMed - indexed for MEDLINE]Related articles

    26.

    Opportunistic infections in persons with HIV or other immunocompromising conditions.

    Kaplan JE, Sepkowitz K, Masur H, Sirisanthana T, Russo M, Chapman L.

    Emerg Infect Dis. 2001;7(3 Suppl):541. No abstract available. PMID: 11485658 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.

    Dworkin MS, Williamson J, Jones JL, Kaplan JE; Adult and Adolescent Spectrum of HIV Disease Project.

    Clin Infect Dis. 2001 Aug 1;33(3):393-8. Epub 2001 Jun 25.PMID: 11438910 [PubMed - indexed for MEDLINE]Related articles

    28.

    Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.

    Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE; Adult and Adolescent Spectrum of HIV Disease Project.

    Clin Infect Dis. 2001 Mar 1;32(5):794-800. Epub 2001 Feb 28.PMID: 11229848 [PubMed - indexed for MEDLINE]Related articles

    29.

    Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds.

    Dworkin MS, Hanson DL, Kaplan JE, Jones JL, Ward JW.

    J Infect Dis. 2000 Aug;182(2):611-5. Epub 2000 Jul 14.PMID: 10915098 [PubMed - indexed for MEDLINE]Related articles

    30.

    Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/l.

    Chapman LE, Green TA, Ahmed F, Parekh BS, Rimland D, Kaplan JE, Thompson MA, Folks TM.

    AIDS. 2000 Jun 16;14(9):1135-46.PMID: 10894277 [PubMed - indexed for MEDLINE]Related articles

    31.

    An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons.

    Kaplan JE, Masur H, Holmes KK, Freedberg KA, Holtgrave D, Piscitelli SC, Van Dyke R, Watts H.

    Clin Infect Dis. 2000 Apr;30 Suppl 1:S15-28. No abstract available. PMID: 10770912 [PubMed - indexed for MEDLINE]Related articles

    32.

    Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

    Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL.

    Clin Infect Dis. 2000 Apr;30 Suppl 1:S5-14. Review.PMID: 10770911 [PubMed - indexed for MEDLINE]Related articles

    33.

    Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

    Masur H, Holmes KK, Kaplan JE.

    Clin Infect Dis. 2000 Apr;30 Suppl 1:S1-4.PMID: 10770910 [PubMed - indexed for MEDLINE]Related articles

    34.

    Protists as opportunistic pathogens: public health impact in the 1990s and beyond.

    Kaplan JE, Jones JL, Dykewicz CA.

    J Eukaryot Microbiol. 2000 Jan-Feb;47(1):15-20. Review.PMID: 10651290 [PubMed - indexed for MEDLINE]Related articles

    35.

    Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.

    Navin TR, Rimland D, Lennox JL, Jernigan J, Cetron M, Hightower A, Roberts JM, Kaplan JE.

    J Infect Dis. 2000 Jan;181(1):158-64.PMID: 10608762 [PubMed - indexed for MEDLINE]Related articles

    36.

    Editorial response: do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease?

    Kaplan JE, Janoff EN, Masur H.

    Clin Infect Dis. 1999 Sep;29(3):544-6. Review. No abstract available. PMID: 10530444 [PubMed - indexed for MEDLINE]Related articles

    37.

    Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama.

    Maloney EM, Armien B, Gracia F, Castillo L, Kruger H, Levin A, Levine PH, Kaplan JE, Blattner WA, Giusti RM.

    J Infect Dis. 1999 Sep;180(3):876-9.PMID: 10438384 [PubMed - indexed for MEDLINE]Related articles

    38.

    Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States.

    Kaplan JE, Parham DL, Soto-Torres L, van Dyck K, Greaves JA, Rauch K, Ellis B, Amandus HE.

    J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):228-35.PMID: 10421247 [PubMed - indexed for MEDLINE]Related articles

    40.

    A 70-kDa amino-terminal fibronectin fragment supports gelatin binding to macrophages and decreases gelatinase activity.

    Penc SF, Blumenstock FA, Kaplan JE.

    J Leukoc Biol. 1998 Sep;64(3):351-7.PMID: 9738662 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Opportunistic infections in immunodeficient populations.

    Kaplan JE, Roselle G, Sepkowitz K.

    Emerg Infect Dis. 1998 Jul-Sep;4(3):421-2. No abstract available. PMID: 9716962 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996.

    Jones JL, Hanson DL, Dworkin MS, Kaplan JE, Ward JW.

    J Infect Dis. 1998 Jul;178(1):114-20.PMID: 9652430 [PubMed - indexed for MEDLINE]Related articles

    43.

    Protein, not adenosine or adenine nucleotides, mediates platelet decrease in endothelial permeability.

    Patil S, Kaplan JE, Minnear FL.

    Am J Physiol. 1997 Nov;273(5 Pt 2):H2304-11.PMID: 9374767 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Preventing opportunistic infections in persons infected with HIV: 1997 guidelines.

    Kaplan JE, Masur H, Jaffe HW, Holmes KK.

    JAMA. 1997 Jul 23-30;278(4):337-8. No abstract available. PMID: 9228443 [PubMed - indexed for MEDLINE]Related articles

    45.

    Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. The Adult/Adolescent Spectrum of Disease Group.

    Jones JL, Hanson DL, Chu SY, Ciesielski CA, Kaplan JE, Ward JW, Navin TR.

    AIDS. 1996 Oct;10(12):1393-9.PMID: 8902069 [PubMed - indexed for MEDLINE]Related articles

    46.

    An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.

    Hershow RC, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein RS, Des Jarlais DC, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan JE.

    J Infect Dis. 1996 Aug;174(2):309-17.PMID: 8699060 [PubMed - indexed for MEDLINE]Related articles

    47.

    Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.

    Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM.

    Am J Trop Med Hyg. 1996 Jul;55(1):1-11. Review.PMID: 8702012 [PubMed - indexed for MEDLINE]Related articles

    48.

    Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group.

    Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, Heneine W, Wright D, Matijas L, Thomson R, Rudolph D, Switzer WM, Kleinman S, Busch M, Schreiber GB.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):193-201.PMID: 8680892 [PubMed - indexed for MEDLINE]Related articles

    49.

    Retroviral risk factors in patients with autoimmune disease.

    Drevlow BE, Schilling EM, Khabbaz RF, Kaplan JE, Fukuda K, Sinacore J, Ramsey-Goldman R.

    J Rheumatol. 1996 Mar;23(3):428-31.PMID: 8832977 [PubMed - indexed for MEDLINE]Related articles

    50.

    14-year follow-up of HIV-infected homosexual men with lymphadenopathy syndrome.

    Kaplan JE, Spira TJ, Fishbein DB, Lyn HS.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):206-8. No abstract available. PMID: 8556407 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...